Influence of CLOCK on cytotoxicity induced by diethylnitrosamine in mouse primary hepatocytes

Toxicology

Volumn 280, Issue 3, 2011, Pages 144-151

  Matsunaga, Naoya ^a   Kohno, Yumiko ^a   Kakimoto, Keisuke ^a   Hayashi, Akane ^a   Koyanagi, Satoru ^a   Ohdo, Shigehiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Clock mutant mouse; Cytotoxicity; Diethylnitrosamine; Primary hepatocyte

Indexed keywords

CASPASE 3; CASPASE 7; DIETHYLNITROSAMINE; GENOMIC DNA; LACTATE DEHYDROGENASE; MESSENGER RNA; TRANSCRIPTION FACTOR CLOCK;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; ENZYME ACTIVITY; GENE MUTATION; LIVER CELL; MALE; MOLECULAR MECHANICS; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WILD TYPE;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CLOCK PROTEINS; CYTOTOXINS; DIETHYLNITROSAMINE; DNA ADDUCTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, MUTANT STRAINS; MUTATION; RNA, SMALL INTERFERING;

EID: 79151469758     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.12.005     Document Type: Article

References (47)

1. Anderson L.E., Morris J.E., Sasser L.B., Stevens R.G. Effect of constant light on DMBA mammary tumorigenesis in rats. Cancer Lett. 2000, 148:121-126.
2. Bae K., Jin X., Maywood E.S., Hastings M.H., Reppert S.M., Weaver D.R. Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 2001, 30:525-536.
3. Bunger M.K., Wilsbacher L.D., Moran S.M., Clendenin C., Radcliffe L.A., Hogenesch J.B., Simon M.C., Takahashi J.S., Bradfield C.A. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 2000, 103:1009-1017.
4. Cheng M.Y., Bullock C.M., Li C., Lee A.G., Bermak J.C., Belluzzi J., Weaver D.R., Leslie F.M., Zhou Q.Y. Prokineticin 2 transmits the behavioral circadian rhythm of the suprachiasmatic nucleus. Nature 2002, 417:405-410.
5. Delaunay F., Laudet V. Circadian clock and microarrays: mammalian genome gets rhythm. Trends Genet. 2002, 18:595-597.
6. Farber J.L., Gerson R.J. Mechanisms of cell injury with hepatotoxic chemicals. Pharmacol. Rev. 1984, 36:71S-75S.
7. Filipski E., King V.M., Li X., Granda T.G., Mormont M.C., Liu X., Claustrat B., Hastings M.H., Levi F. Host circadian clock as a control point in tumor progression. J. Natl. Cancer Inst. 2002, 94:690-697.
8. Filipski E., Subramanian P., Carrière J., Guettier C., Barbason H., Lévi F. Circadian disruption accelerates liver carcinogenesis in mice. Mutat. Res. 2009, 680:95-105.
9. Fu L., Pelicano H., Liu J., Huang P., Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002, 111:41-50.
10. Galli F., Rossi M., D'Alessandra Y., De Simone M., Lopardo T., Haupt Y., Alsheich-Bartok O., Anzi S., Shaulian E., Calabrò V., La Mantia G., Guerrini L. MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. J. Cell Sci. 2010, 123:2423-2433.
11. Gekakis N., Staknis D., Nguyen H.B., Davis F.C., Wilsbacher L.D., King D.P., Takahashi J.S., Weitz C.J. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998, 280:1564-1569.
12. Gery S., Komatsu N., Baldjyan L., Yu A., Koo D., Koeffler H.P. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol. Cell 2006, 22:375-382.
13. Gorbacheva V.Y., Kondratov R.V., Zhang R., Cherukuri S., Gudkov A.V., Takahashi J.S., Antoch M.P. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:3407-3412.
14. Guzman R.E., Solter P.F., Runnegar M.T. Inhibition of nuclear protein phosphatase activity in mouse hepatocytes by the cyanobacterial toxin microcystin-LR. Toxicon 2003, 41:773-781.
15. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001, 12:74-77.
16. Hua H., Wang Y., Wan C., Liu Y., Zhu B., Yang C., Wang X., Wang Z., Cornelissen-Guillaume G., Halberg F. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 2006, 97:589-596.
17. Jin X., Shearman L.P., Weaver D.R., Zylka M.J., de Vries G.J., Reppert S.M. A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell 1999, 96:57-68.
18. Kennaway D.J., Voultsios A., Varcoe T.J., Moyer R.W. Melatonin and activity rhythm responses to light pulses in mice with the Clock mutation. Am. J. Physiol. 2003, 284:R1231-1240.
19. Kim J., Matsunaga N., Koyanagi S., Ohdo S. Clock gene mutation modulates the cellular sensitivity to genotoxic stress through altering the expression of N-methylpurine DNA glycosylase gene. Biochem. Pharmacol. 2009, 78:1075-1082.
20. Kita Y., Shiozawa M., Jin W., Majewski R.R., Besharse J.C., Greene A.S., Jacob H.J. Implications of circadian gene expression in kidney, liver and the effects of fasting on pharmacogenomic studies. Pharmacogenetics 2002, 12:55-65.
21. Koyanagi S., Kuramoto Y., Nakagawa H., Aramaki H., Ohdo S., Soeda S., Shimeno H. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res. 2003, 63:7277-7283.
22. Kume K., Zylka M.J., Sriram S., Sherman L.P., Weaver D.R., Jin X., Maywood E.S., Hastings M.H., Reppert S.M. mCRY1 and CRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 1999, 98:193-205.
23. Lake B.G., Price R.J., Giddings A.M., Walters D.G. In vitro assays for induction of drug metabolism. Methods Mol. Biol. 2009, 481:47-58.
24. Leffert H.L., Moran T., Boorstein R., Koch K.S. Procarcinogen activation and hormonal control of cell proliferation in differentiated primary adult rat liver cell cultures. Nature 1977, 267:58-61.
25. Lowrey P.L., Takahashi J.S. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu. Rev. Genom. Hum. Genet. 2004, 5:407-441.
26. Marine J.C., Francoz S., Maetens M., Wahl G., Toledo F., Lozano G. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ. 2006, 13:927-934.
27. Miller B.H., Olson S.L., Turek F.W., Levine J.E., Horton T.H., Takahashi J.S. Circadian clock mutation disrupts estrous cyclicity and maintenance of pregnancy. Curr. Biol. 2004, 14:1367-1373.
28. Miller B.H., McDearmon E.L., Panda S., Hayes K.R., Zhang J., Andrews J.L., Antoch M.P., Walker J.R., Esser K.A., Hogenesch J.B., Takahashi J.S. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:3342-3347.
29. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299.
30. Mormont M.C., Levi F. Circadian-system alterations during cancer processes: a review. Int. J. Cancer 1997, 70:241-247.
31. Nakatsuru Y., Matsukuma S., Nemoto N., Sugano H., Sekiguchi M., Ishikawa T. O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:6468-6472.
32. Ochi M., Sono S., Sei H., Oishi K., Kobayashi H., Morita Y., Ishida N. Sex difference in circadian period of body temperature in Clock mutant mice with Jcl/ICR background. Neurosci. Lett. 2003, 347:163-166.
33. Ohdo S., Koyanagi S., Suyama H., Higuchi S., Aramaki H. Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nat. Med. 2001, 3:356-360.
34. Oishi K., Fukui H., Ishida N. Rhythmic expression of BMAL1 mRNA is altered in Clock mutant mice: differential regulation in the suprachiasmatic nucleus and peripheral tissues. Biochem. Biophys. Res. Commun. 2000, 268:164-171.
35. Oishi K., Miyazaki K., Ishida N. Functional CLOCK is not involved in the entrainment of peripheral clocks to the restricted feeding: entrainable expression of mPer2 and BMAL1 mRNAs in the heart of Clock mutant mice on Jcl: ICR background. Biochem. Biophys. Res. Commun. 2003, 298:198-202.
36. Pääjärvi G., Viluksela M., Pohjanvirta R., Stenius U., Högberg J. TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents. Carcinogenesis 2005, 26:201-208.
37. Panda S., Antoch M.P., Miller B.H., Su A.I., Schook A.B., Straume M., Schultz P.G., Kay S.A., Takahashi J.S., Hogenesch J.B. Coordinatedtranscription of key pathways in the mouse by the circadian clock. Cell 2002, 109:307-320.
38. Ripperber J.A., Shearman L.P., Reppert S.M., Schibler U. CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP. Genes Dev. 2000, 14:679-689.
39. Schernhammer E.S., Laden F., Speizer F.E., Willett W.C., Hunter D.J., Kawachi I., Colditz G.A. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J. Natl. Cancer Inst. 2001, 93:1563-1568.
40. Shieh S.Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997, 91:325-334.
41. Stephan F.K., Zucker I. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc. Natl. Acad. Sci. U.S.A. 1972, 69:1583-1586.
42. Storch K.F., Leykin I., Viswanathan N., Davis F.C., Wong W.H., Weitz C.J. Extensive and divergent circadian gene expression in liver and heart. Nature 2002, 417:78-83.
43. Van der Horst G.T., Muijtjens M., Kobayashi K., Takano R., Kanno S., Takao M., de Wit J., Verkerk A., Eker A.P., van Leenen D., Buijs R., Bootsma D., Hoeijmakers J.H., Yasui A. Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature 1999, 398:627-630.
44. Verna L., Whysner J., Williams G.M. N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol. Ther. 1996, 71:57-81.
45. Vitaterna M.H., King D.P., Chang A.M., Kornhauser J.M., Lowrey P.L., McDonald J.D., Dove W.F., Pinto L.H., Turek F.W., Takahashi J.S. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science 1994, 264:719-725.
46. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., Korsmeyer S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292:727-730.
47. Zheng B., Albrecht U., Kaasik K., Sage M., Lu W., Vaishnav S., Li Q., Sun Z.S., Eichele G., Bradley A., Lee C.C. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 2001, 105:683-694.